Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus

Regulatory Peptides

Volumn 178, Issue 1-3, 2012, Pages 6-10

  Erdmann, Johannes ^a   Salmhofer, Hermann ^b   Knauß, Amelie ^a   Mayr, Martina ^a   Wagenpfeil, Stefan ^a   Sypchenko, Oleg ^c   Luppa, Peter ^a   Schusdziarra, Volker ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF SALZBURG   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

BMR; HOMA IR; Obesity; Overweight

Indexed keywords

FETUIN A; GLUCOSE; HEMOGLOBIN A1C; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; WEIGHT GAIN;

ADULT; ALPHA-2-HS-GLYCOPROTEIN; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; STATISTICS, NONPARAMETRIC;

EID: 84865352401     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.02.004     Document Type: Article

References (31)

1. Krotkiewski M., Bjorntorp P., Sjostrom L., Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983, 72:1150-1162.
2. Evans D.J., Murray R., Kissebah A.H. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest 1984, 74:1515-1525.
3. Hollenbeck C., Reaven G.M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987, 64:1169-1173.
4. Walton C., Godsland I.F., Proudler A.J., Felton C.V., Wynn V. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab 1992, 75:170-175.
5. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997, 100:1166-1173.
6. Erdmann J., Kallabis B., Oppel U., Sypchenko O., Wagenpfeil S., Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 2008, 294:E568-E575.
7. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
8. Denecke B., Graber S., Schafer C., Heiss A., Woltje M., Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 2003, 376:135-145.
9. Auberger P., Falquerho L., Contreres J.O., Pages G., Le Cam G., Rossi B., Le Cam A. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 1989, 58:631-640.
10. Rauth G., Poschke O., Fink E., Eulitz M., Tippmer S., Kellerer M., Haring H.U., Nawratil P., Haasemann M., Jahnen-Dechent W. The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem 1992, 204:523-529.
11. Mathews S.T., Chellam N., Srinivas P.R., Cintron V.J., Leon M.A., Goustin A.S., Grunberger G. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000, 164:87-98.
12. Mathews S.T., Singh G.P., Ranalletta M., Cintron V.J., Qiang X., Goustin A.S., Jen K.L., Charron M.J., Jahnen-Dechent W., Grunberger G. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002, 51:2450-2458.
13. Mathews S.T., Rakhade S., Zhou X., Parker G.C., Coscina D.V., Grunberger G. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem Biophys Res Commun 2006, 350:437-443.
14. Stefan N., Hennige A.M., Staiger H., Machann J., Schick F., Krober S.M., Machicao F., Fritsche A., Haring H.U. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006, 29:853-857.
15. Mori K., Emoto M., Yokoyama H., Araki T., Teramura M., Koyama H., Shoji T., Inaba M., Nishizawa Y. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006, 29:468.
16. Ix J.H., Shlipak M.G., Brandenburg V.M., Ali S., Ketteler M., Whooley M.A. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006, 113:1760-1767.
17. Lehtinen A.B., Burdon K.P., Lewis J.P., Langefeld C.D., Ziegler J.T., Rich S.S., Register T.C., Carr J.J., Freedman B.I., Bowden D.W. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 2007, 92:345-352.
18. Weikert C., Stefan N., Schulze M.B., Pischon T., Berger K., Joost H.G., Haring H.U., Boeing H., Fritsche A. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008, 118:2555-2562.
19. Roos M., Lutz J., Salmhofer H., Luppa P., Knauss A., Braun S., Martinof S., Schömig A., Heemann U., Kastrati A., Hausleiter J. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) 2008, 68:660-665.
20. Ix J.H., Wassel C.L., Kanaya A.M., Vittinghoff E., Johnson K.C., Koster A., Cauley J.A., Harris T.B., Cummings S.R., Shlipak M.G. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008, 300:182-188.
21. Stefan N., Fritsche A., Weikert C., Boeing H., Joost H.G., Haring H.U., Schulze M.B. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008, 57:2762-2767.
22. Erdmann J., Mayr M., Oppel U., Sypchenko O., Wagenpfeil S., Schusdziarra V. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regul Pept 2009, 152:1-7.
23. Brix J.M., Stingl H., Hollerl F., Schernthaner G.H., Kopp H.P., Schernthaner G. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab 2010, 95:4877-4881.
24. Erdmann J., Lippl F., Wagenpfeil S., Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 2005, 54:1371-1378.
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 7:412-419.
26. Ix J.H., Wassel C.L., Chertow G.M., Koster A., Johnson K.C., Tylavsky F.A., Cauley J.A., Cummings S.R., Harris T.B., Shlipak M.G. Fetuin-A and change in body composition in older persons. J Clin Endocrinol Metab 2009, 94:4492-4498.
27. Ishibashi A., Ikeda Y., Ohguro T., Kumon Y., Yamanaka S., Takata H., Inoue M., Suehiro T., Terada Y. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb 2010, 17:925-933.
28. Reinehr T., Roth C.L. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008, 93:4479-4485.
29. Kaushik S.V., Plaisance E.P., Kim T., Huang E.Y., Mahurin A.J., Grandjean P.W., Mathews S.T. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev 2009, 25:427-434.
30. Mori K., Emoto M., Araki T., Yokoyama H., Lee E., Teramura M., Koyama H., Shoji T., Inaba M., Nishizawa Y. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism 2008, 57:1248-1252.
31. Tonjes A., Fasshauer M., Kratzsch J., Stumvoll M., Bluher M. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One 2010, 5:e13911.